Interactions between anticholinesterases in an in vitro central
nervous system preparation
Interactions between anticholinesterases in an in vitro central
nervous system preparation
Organophosphate compounds have been widely developed as pesticides (e.g. paraoxon)
and also as chemical warfare agents (nerve agents, e.g. sarin). These compounds rapidly
inhibit the enzyme acetylcholinesterase (AChE), causing overstimulation within the
cholinergic nervous system. If left untreated, this can be fatal. Current medical
countermeasures to nerve agent poisoning consist of pretreatment with pyridostigmine
and an emergency therapy comprising atropine, diazepam and pralidoxime. As well as a
replacement pretreatment for pyridostigmine, physostigmine has been proposed as a
component of a next generation of therapy to nerve agent poisoning, along with
scopolamine and HI6. In animal studies, this therapy has been shown to lessen the level
of incapacitation and increase survivability post poisoning with nerve agent. The exact
mechanism of action of physostigmine in this combination is as yet unclear.
The primary aim of this study was to test the hypothesis that the beneficial effect of
physostigmine in the proposed therapy is due to reversible inhibition of AChE, thereby
protecting it from irreversible inhibition by nerve agent. To test this, extracellular field
potentials were recorded from the molecular layer of the dentate gyrus in an in vitro slice
model developed from the guinea pig. This response was shown to be modulated by the
application of physostigmine and the nerve agent sarin and interactions between the two
inhibitors were characterised. The results provided evidence for protection of ChE by
physostigmine. The functional response (field potential) was related to cholinesterase
activity measured in slices exposed to sarin.
This is the first evidence of the mechanism of action of physostigmine protection against
nerve agent in the CNS. Not only will these results support the use of physostigmine as a
pre-treatment, it also supports its use as a possible immediate therapy.
Scott, Iain Ratcliffe
2891cc93-4658-4615-a86c-fe744d8075f2
December 2008
Scott, Iain Ratcliffe
2891cc93-4658-4615-a86c-fe744d8075f2
Pringle, Ashley
6339ed95-c491-43a8-b2fb-2384466dc80d
Sundstrom, L
370d5aa7-aec4-417a-b813-b27936dd2d69
Tatterstall, J
eb1ed5f8-59bf-49d8-8460-29a28b45605c
Scott, Iain Ratcliffe
(2008)
Interactions between anticholinesterases in an in vitro central
nervous system preparation.
University of Southampton, School of Medicine, Doctoral Thesis, 187pp.
Record type:
Thesis
(Doctoral)
Abstract
Organophosphate compounds have been widely developed as pesticides (e.g. paraoxon)
and also as chemical warfare agents (nerve agents, e.g. sarin). These compounds rapidly
inhibit the enzyme acetylcholinesterase (AChE), causing overstimulation within the
cholinergic nervous system. If left untreated, this can be fatal. Current medical
countermeasures to nerve agent poisoning consist of pretreatment with pyridostigmine
and an emergency therapy comprising atropine, diazepam and pralidoxime. As well as a
replacement pretreatment for pyridostigmine, physostigmine has been proposed as a
component of a next generation of therapy to nerve agent poisoning, along with
scopolamine and HI6. In animal studies, this therapy has been shown to lessen the level
of incapacitation and increase survivability post poisoning with nerve agent. The exact
mechanism of action of physostigmine in this combination is as yet unclear.
The primary aim of this study was to test the hypothesis that the beneficial effect of
physostigmine in the proposed therapy is due to reversible inhibition of AChE, thereby
protecting it from irreversible inhibition by nerve agent. To test this, extracellular field
potentials were recorded from the molecular layer of the dentate gyrus in an in vitro slice
model developed from the guinea pig. This response was shown to be modulated by the
application of physostigmine and the nerve agent sarin and interactions between the two
inhibitors were characterised. The results provided evidence for protection of ChE by
physostigmine. The functional response (field potential) was related to cholinesterase
activity measured in slices exposed to sarin.
This is the first evidence of the mechanism of action of physostigmine protection against
nerve agent in the CNS. Not only will these results support the use of physostigmine as a
pre-treatment, it also supports its use as a possible immediate therapy.
Text
Iain_Scott_Final_PhD_Thesis_2008.pdf
- Other
More information
Published date: December 2008
Organisations:
University of Southampton
Identifiers
Local EPrints ID: 72908
URI: http://eprints.soton.ac.uk/id/eprint/72908
PURE UUID: 713709bd-aadd-460a-91f9-1dd6825109a4
Catalogue record
Date deposited: 16 Mar 2010
Last modified: 14 Mar 2024 02:38
Export record
Contributors
Author:
Iain Ratcliffe Scott
Thesis advisor:
L Sundstrom
Thesis advisor:
J Tatterstall
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics